Skip to main content
Clinical Trials/NCT00015223
NCT00015223
Completed
Phase 2

Methyphendidate in the Treatment of Cocaine Dependent Patients With Adult ADHD

National Institute on Drug Abuse (NIDA)1 site in 1 countryJune 1997

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cocaine-Related Disorders
Sponsor
National Institute on Drug Abuse (NIDA)
Locations
1
Primary Endpoint
Psychosocial counseling sessions
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is the use of Methylphenidate in the treatment of cocaine dependence and Attention Deficit Hyperactivity Disorder (ADHD) comorbidity.

Detailed Description

The objective of this study is to determine the safety and efficacy of methylphenidate in a population of patients who are cocaine dependent and suffer from attention deficit hyperactivity disorder.

Registry
clinicaltrials.gov
Start Date
June 1997
End Date
August 1999
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Cocaine-dependent. Meets the DSM-IV criteria for ADHD. Actively using cocaine within the past 30 days of screening.

Exclusion Criteria

  • Symptoms of AIDS. Significant medical disorder. DSM-IV criteria for any substance other than cocaine, alcohol, nicotine, marijuana, caffeine. Requires detoxification from ETOH or benzos. History of seizures.

Outcomes

Primary Outcomes

Psychosocial counseling sessions

Safety assessments

Cocaine use

Methylphenidate retention

Study Sites (1)

Loading locations...

Similar Trials